Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.81 USD
−61.62 M USD
2.55 B USD
113.57 M
About Evolent Health, Inc
Sector
CEO
Seth B. Blackley
Website
Headquarters
Arlington
Founded
2011
FIGI
BBG005CHLM96
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.
$EVHPotential abc wave located. Looking for price to retrace to 11.97. Entered a trade beforehand with a 19.24 target but this post is for the 11.97.
$EVH*For share traders only. Not meant for options.
Green: Entry Point
Blue: Start of Week
Red: End of Week
Thumbs Up: Trade Available for Week
$ Amount (Numbers Above): Price Targets
*I don’t believe in sharing strategies or outlooks due to the idea that it could cause someone confusion within. It’s
EVH, 5/14-5/29, -9.5% LOSSOn 5/9/2024, Evolent Health (EVH) reported earnings of $0.16 per share on revenue of $639.65 million for the first quarter ended March 2024. The consensus earnings estimate was $0.12 per share on revenue of $601.60 million. The company beat consensus estimates by 33.33% while revenue grew 49.56% on
EVH, 2/27-4/2, -9.5% LossOn 2/22/2024, Evolent Health (EVH) reported earnings of $0.15 per share on revenue of $556.06 million for the fourth quarter ended December 2023. The consensus earnings estimate was $0.02 per share on revenue of $542.39 million.
EVH (Evolent Health) Buy TF H4 TP = 30.08On the 4-hour chart the trend started on August 29 (linear regression channel).
There is a high probability of profit taking. Possible take profit level is 30.08
But we should not forget about SL = 24.64
Using a trailing stop is also a good idea!
Please leave your feedback, your opinion. I am
EVH (Evolent Health, Inc. ) Buy TF H1 TP = 30.65On the hour chart the trend started on August 7 (linear regression channel).
There is a high probability of profit taking. Possible take profit level is 30.65
But we should not forget about SL = 27.71
Using a trailing stop is also a good idea!
Please leave your feedback, your opinion. I am ve
sell EVH short1. ER disaster & Bounce and roll structure
2. break volume POC
3. MA congestion
4. Lower high and reversal at high. Cannot break 50MA
Also note the negative vol profile
Fundamental peaked. Next year earning negative and decreasing but PE still high, may need to catch up to the downside.
This coul
Descending Triangle Price is below support line.
Oversold.
Price remains above the .382 of the trend up.
Earning's date conflicts, but is early November.
No recommendation.
EPS (FWD)
0.40
PE (FWD)
75.93
Div Rate (TTM)
Short Interest
7.88%
Market Cap
$2.95B
Evolent Health, Inc., a healthcare company, through its su
EVH , LONG Primary buy on EVH
I like how it wedge pops and pulls above GLB on same day . GLB marked in green line .
Lets see if it works out .
Entry 34.74
Stop 33.60
PT 1 - 36.02 , sell 1/4 , stop up
PT 2 - 37.23
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
EVH5958944
Evolent Health, Inc. 3.5% 01-DEC-2029Yield to maturity
10.00%
Maturity date
Dec 1, 2029
EVH4901961
Evolent Health, Inc. 1.5% 15-OCT-2025Yield to maturity
7.93%
Maturity date
Oct 15, 2025
See all EVH bonds
Related stocks
Frequently Asked Questions
The current price of EVH is 9.79 USD — it has decreased by −1.65% in the past 24 hours. Watch Evolent Health, Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Evolent Health, Inc stocks are traded under the ticker EVH.
EVH stock has risen by 3.08% compared to the previous week, the month change is a 2.23% rise, over the last year Evolent Health, Inc has showed a −67.83% decrease.
We've gathered analysts' opinions on Evolent Health, Inc future price: according to them, EVH price has a max estimate of 20.00 USD and a min estimate of 12.00 USD. Watch EVH chart and read a more detailed Evolent Health, Inc stock forecast: see what analysts think of Evolent Health, Inc and suggest that you do with its stocks.
EVH stock is 4.93% volatile and has beta coefficient of −0.96. Track Evolent Health, Inc stock price on the chart and check out the list of the most volatile stocks — is Evolent Health, Inc there?
Today Evolent Health, Inc has the market capitalization of 1.14 B, it has decreased by −2.89% over the last week.
Yes, you can track Evolent Health, Inc financials in yearly and quarterly reports right on TradingView.
Evolent Health, Inc is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
EVH earnings for the last quarter are −0.02 USD per share, whereas the estimation was 0.03 USD resulting in a −166.54% surprise. The estimated earnings for the next quarter are 0.09 USD per share. See more details about Evolent Health, Inc earnings.
Evolent Health, Inc revenue for the last quarter amounts to 646.54 M USD, despite the estimated figure of 651.31 M USD. In the next quarter, revenue is expected to reach 460.58 M USD.
EVH net income for the last quarter is −22.80 M USD, while the quarter before that showed −23.14 M USD of net income which accounts for 1.45% change. Track more Evolent Health, Inc financial stats to get the full picture.
No, EVH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 4.5 K employees. See our rating of the largest employees — is Evolent Health, Inc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Evolent Health, Inc EBITDA is 123.11 M USD, and current EBITDA margin is 4.91%. See more stats in Evolent Health, Inc financial statements.
Like other stocks, EVH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Evolent Health, Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Evolent Health, Inc technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Evolent Health, Inc stock shows the sell signal. See more of Evolent Health, Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.